Bikoue Arsene, Janossy George, Barnett David
HIV Immunology, Department of Immunology and Molecular Pathology, Royal Free and University College Medical School, Hampstead, London, UK.
J Immunol Methods. 2002 Aug 1;266(1-2):19-32. doi: 10.1016/s0022-1759(02)00094-7.
We first confirmed the precision of the quantitative indirect immunofluorescence (QIFI) test by demonstrating that blood lymphocytes from different individuals expressed CD45 leucocyte antigens at a very similar level (mean: 201 x 10(3) antibody binding capacity (ABC)/lymphocyte) with only minimal variation (CV% 2.5%). These values were maintained for 4 days in blood samples when kept at 20 degrees C, and for up to 14 days in samples fixed with TransFix. Using long-term stabilisation, after an initial drop of 10-15% the CD45 ABC/lymphocyte values remained stable at an 85-90% level for >1 year. These biological standards were used to check other quantitative IF techniques. The quantum simply cellular (QSC) method showed variable results (85-240%), and the QuantiBRITE method gave values as low as 30-40% of the expected values, indicating that biological standards such as CD45 ABC/lymphocytes are absolutely essential to check the performance of methods that claim to quantify immunofluorescence (IF). Next, these standards were used to establish the stabilised cellular immuno-fluorescence assay (SCIFA) as follows. The ABC x 10(3)/cell values established by QIFI on leucocyte populations such as lympho-, mono- and granulocytes were used to create calibration curves for the CD45 antigen and its isoforms CD45RA, -R0 and -RB. The same cell populations were then stained with monoclonal antibodies (MAbs) directly conjugated to different fluorochromes in order to translate the mean fluorescence intensity (MFI) values seen with the directly labelled reagents to values of ABCx10(3)/cells. Using SCIFA with a triple-colour direct IF, the display of CD45 and its isoforms were quantitated on the 'virgin' or 'unprimed' (CD45RA+) and 'primed' (CD45R0+) subsets in both the CD4+ and CD8+ T cell lineages. We also observed that the CD4+ and CD8+ T cells in transit between the 'virgin' and 'primed' subsets frequently displayed different levels of the CD45RA and -R0 molecules, pointing to the physiological variability of the CD45RA-R0 switching process. In conclusion, internal biological standards, with known stable expression of ABC/cell, should be used to evaluate IF staining patterns in a quantitative manner during routine investigations.
我们首先通过证明来自不同个体的血液淋巴细胞以非常相似的水平表达CD45白细胞抗原(平均值:201×10³抗体结合能力(ABC)/淋巴细胞)且变异极小(CV% 2.5%),证实了定量间接免疫荧光(QIFI)检测的精度。当血液样本保存在20℃时,这些值在4天内保持稳定,在用TransFix固定的样本中可保持长达14天。使用长期稳定化方法,在最初下降10 - 15%后,CD45 ABC/淋巴细胞值在85 - 90%的水平保持稳定超过1年。这些生物学标准用于检查其他定量免疫荧光技术。量子单细胞(QSC)方法显示结果可变(85 - 240%),而QuantiBRITE方法给出的值低至预期值的30 - 40%,这表明诸如CD45 ABC/淋巴细胞之类的生物学标准对于检查声称可定量免疫荧光(IF)的方法的性能绝对至关重要。接下来,这些标准用于建立稳定化细胞免疫荧光测定法(SCIFA),具体如下。通过QIFI在淋巴细胞、单核细胞和粒细胞等白细胞群体上建立的ABC×10³/细胞值用于创建CD45抗原及其异构体CD45RA、-R0和-RB的校准曲线。然后用直接与不同荧光染料偶联的单克隆抗体(MAb)对相同的细胞群体进行染色,以便将直接标记试剂所见的平均荧光强度(MFI)值转化为ABC×10³/细胞值。使用三色直接免疫荧光的SCIFA,在CD4⁺和CD8⁺T细胞谱系的“原始”或“未致敏”(CD45RA⁺)和“致敏后”(CD45R0⁺)亚群上对CD45及其异构体进行定量。我们还观察到,在“原始”和“致敏后”亚群之间过渡的CD4⁺和CD8⁺T细胞经常显示出不同水平的CD45RA和-R0分子,这表明CD45RA - R0转换过程存在生理变异性。总之,在常规研究期间,应使用具有已知稳定ABC/细胞表达的内部生物学标准以定量方式评估免疫荧光染色模式。